ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 210 filers reported holding ANACOR PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,407,000 | -87.4% | 54,476 | -93.2% | 0.30% | -87.4% |
| Q1 2016 | $42,841,000 | -59.3% | 801,510 | -13.9% | 2.36% | -54.0% |
| Q4 2015 | $105,207,000 | +51.8% | 931,287 | +58.1% | 5.12% | +53.0% |
| Q3 2015 | $69,321,000 | -37.1% | 588,912 | -58.6% | 3.34% | -22.4% |
| Q2 2015 | $110,161,000 | +69.5% | 1,422,708 | +26.7% | 4.31% | +56.3% |
| Q1 2015 | $64,973,000 | +97.7% | 1,123,135 | +10.2% | 2.76% | +92.9% |
| Q4 2014 | $32,872,000 | +44.9% | 1,019,275 | +9.9% | 1.43% | +40.2% |
| Q3 2014 | $22,693,000 | -5.5% | 927,754 | -31.6% | 1.02% | +10.6% |
| Q2 2014 | $24,026,000 | -1.4% | 1,355,847 | +11.2% | 0.92% | -26.0% |
| Q1 2014 | $24,378,000 | -11.9% | 1,219,519 | -26.2% | 1.24% | -1.8% |
| Q4 2013 | $27,678,000 | +53.2% | 1,651,437 | -3.0% | 1.27% | +43.0% |
| Q3 2013 | $18,061,000 | +65.1% | 1,702,300 | -13.0% | 0.89% | +37.1% |
| Q2 2013 | $10,941,000 | – | 1,957,300 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $61,778,000 | 25.76% |
| VHCP Management, LLC | 1,178,474 | $68,175,000 | 15.70% |
| Palo Alto Investors LP | 3,259,045 | $188,536,000 | 9.32% |
| HWG Holdings LP | 69,898 | $4,044,000 | 6.53% |
| Consonance Capital Management LP | 830,151 | $48,024,000 | 4.37% |
| EMORY UNIVERSITY | 23,325 | $1,349,000 | 2.55% |
| Baker Brothers Advisors | 4,204,702 | $243,242,000 | 2.02% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 117,875 | $6,819,000 | 1.55% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 595,300 | $34,438,000 | 1.46% |
| Century Capital Management, LLC | 1,030,483 | $45,609,000 | 1.31% |